References
George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654–666. https://doi.org/10.1056/nejmra1312353
Chiasakul T, Cuker A (2018) Clinical and laboratory diagnosis of TTP: an integrated approach. Hematol (United States) 1:530–538. https://doi.org/10.1182/asheducation-2018.1.530
Camilleri RS, Scully M, Thomas M et al (2012) A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom. J Thromb Haemost 10(9):1792–1801. https://doi.org/10.1111/j.1538-7836.2012.04852.x
Deal T, Kremer Hovinga JA, Marques MB, Adamski J (2013) Novel ADAMTS13 mutations in an obstetric patient with Upshaw-Schulman syndrome. J Clin Apher 28(4):311–316. https://doi.org/10.1002/jca.21251
Bu F, Maga T, Meyer NC et al (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25(1):55–64. https://doi.org/10.1681/ASN.2013050453
Feitz WJC, van de Kar NCAJ, Orth-Höller D, van den Heuvel LPJW, Licht C (2018) The genetics of atypical hemolytic uremic syndrome. Medizinische Genet 30(4):400–409. https://doi.org/10.1007/s11825-018-0216-0
Noris M, Remuzzi G (2009) Atypical hemolytic–uremic syndrome. N Engl J Med 361(17):1676–1687. https://doi.org/10.1056/NEJMra0902814
Modde F, Agustian PA, Wittig J et al (2013) Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). Virchows Arch 462(4):455–464. https://doi.org/10.1007/s00428-013-1386-4
Acknowledgements
We are deeply thankful to Dr. Anandita A. Datta, MD (Nephropathologist, The Joint Pathology Center, Defense Health Agency, Silver Spring, MD) for her help in obtaining the photomicrographs of the kidney biopsy for this patient.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The patient described in this letter gave his informed consent prior to preparing this letter.
Competing interests
The authors declare no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tiwari, N.R., Arora, S., Tolat, A.G. et al. TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant. Ann Hematol 101, 725–727 (2022). https://doi.org/10.1007/s00277-021-04589-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-021-04589-7